Management

Clemmer, James C.
President and Chief Executive Officer
James Clemmer

President and Chief Executive Officer James Clemmer joined AngioDynamics in April 2016, bringing more than 25 years of leadership within the healthcare industry and a proven track record of success.

Prior to AngioDynamics, Clemmer served as president of the $1.8 billion medical supplies segment at Covidien plc., where he directed strategic and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the medical supplies business. Prior to his role at Covidien, Clemmer served as group president at Kendall Healthcare, where he managed the US business across five divisions and built the strategic plan for the Medical Supplies segment before it was spun off from Tyco. Clemmer began his career at Sage Products, Inc.

Clemmer currently serves on the Board of Directors for AngioDynamics and Lantheus Medical Imaging. Clemmer is a graduate of the Massachusetts College of Liberal Arts. 
 

Greiner, Michael C.
Executive Vice President and Chief Financial Officer
Michael Greiner

Executive Vice President and Chief Financial Officer Michael C. Greiner joined AngioDynamics in August 2016, bringing more than 20 years of experience in accounting, corporate finance and operations.

Prior to AngioDynamics, Greiner served as the Chief Financial Officer at Extreme Reach, Inc., a cloud-based enterprise platform for brand advertising, responsible for all finance and human resource operations. Prior to his role at Extreme Reach, Greiner held several executive roles, including Senior Vice President Corporate Finance and Chief Accounting Officer at Cimpress N.V. (formerly known as Vistaprint N.V.), Global Controller for GE’s Water and Processing Technologies division and leadership roles at Bausch & Lomb and Wyeth.

Greiner has also served as an adjunct professor at several universities and earned a Master’s in Business Administration from Columbia University Business School, as well as a Bachelor and Master of Science in Accounting from Fairleigh Dickinson University.  Greiner is a certified public accountant and an advisor for Mirah, Inc., a mental healthcare technology start-up. Greiner also currently serves as the President of the Foundation for Faces of Children. 

Campbell, Chad
Senior Vice President and General Manager, Vascular Access
Chad Campbell

Senior Vice President and General Manager, Vascular Access, Chad Campbell joined the AngioDynamics team in May 2016 bringing more than 20 years of sales and marketing experience. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien. During his tenure at Covidien, Campbell also held roles as Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell holds a Bachelor of Arts degree from the University of Kentucky.

Stark, Rick
Senior Vice President, Global Franchise, Oncology/Surgery
Rick Stark

Senior Vice President, Global Franchise, Oncology/Surgery, Rick Stark's tenure with AngioDynamics has been distinguished by his dedicated leadership and ability to drive the Company's Oncology/Surgery products. He began his 12-year career with the Company as a District Sales Manager with RITA Medical in 1999, which was acquired by AngioDynamics in 2007, and most recently served as AngioDynamics' Vice President of Sales and Marketing of the Oncology/Surgery Division. Mr. Stark has been instrumental in the research and development, and commercialization of the division's portfolio. Prior to joining RITA, he spent several years in field sales roles at Woodside Biomedical and Arrow/Teleflex. He has a Bachelor's in Psychology from California State University of Chico in Chico, Calif.

  • Stock Information
  • Ticker ANGO
    Exchange NASDAQ
    Price $17.10
    Change + 0.05
    Volume 459,833
    Aug 18, 2017 - 4:00 PM ET
  • Search Investor Relations